Administration of propranolol in patients with pheochromocytoma can lead to sudden pulmonary edema and shock due to unopposed alpha effects.
May warrant caution with IV propranolol in pheochromocytoma; leaves open need for systematic safety data.
Sudden onset of pulmonary edema after administration of intravenous propranolol hydrochloride developed in a patient with pheochromocytoma but without clinical or histological evidence of heart disease. Previous cases of pulmonary edema have been reported in association with oral propranolol therapy but have failed to document histological absence of cardiac pathology. The mechanism for the development of pulmonary edema may have been a propranolol-induced beta 1- and beta 2-blockade that led to unopposed alpha effects and sudden elevation of afterload. This case underlines the caution that should be used in the administration of propranolol when the diagnosis of pheochromocytoma is considered.
No takes yet. Share an insight, caveat, or question.
Elaine M. Sloand (1984) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: